Gendreau has more than 25 years of experience serving as the Chief Medical Officer for both private and public biotechnology companies involved in diagnostics, pharmaceuticals, and medical devices.
His areas of expertise are rheumatology, functional somatic syndromes, chronic and acute pain, schizophrenia, depression, anxiety, and cognition disorders.
Dr. Gendreau was a founding member and Chief Medical Officer of Cypress Bioscience, Inc. He received a BS in Chemistry from Ohio University and MD and PhD degrees in Pharmacology from The Ohio State University.